abstract |
The present invention discloses compounds according to Formula I: n n n n n n n n n n Wherein R 1 , R 2 , R 3a , R 3b , R 6 , Cy, and the subscript n are as defined herein. n The present invention relates to compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis by administering the compound of the invention. |